Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Preferred Dividend Payments (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Preferred Dividend Payments for 15 consecutive years, with $7000.0 as the latest value for Q4 2025.

  • Quarterly Preferred Dividend Payments rose 16.67% to $7000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25000.0 through Dec 2025, up 4.17% year-over-year, with the annual reading at $25000.0 for FY2025, 4.17% up from the prior year.
  • Preferred Dividend Payments hit $7000.0 in Q4 2025 for Cardiff Oncology, up from $6000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $7000.0 in Q4 2025 to a low of $6000.0 in Q1 2021.
  • Historically, Preferred Dividend Payments has averaged $6050.0 across 5 years, with a median of $6000.0 in 2021.
  • Biggest five-year swings in Preferred Dividend Payments: changed 0.0% in 2021 and later rose 16.67% in 2025.
  • Year by year, Preferred Dividend Payments stood at $6000.0 in 2021, then changed by 0.0% to $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024, then rose by 16.67% to $7000.0 in 2025.
  • Business Quant data shows Preferred Dividend Payments for CRDF at $7000.0 in Q4 2025, $6000.0 in Q3 2025, and $6000.0 in Q2 2025.